Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Canavero, Isabella ^a   Cavallini, Anna ^a   Perrone, Patrizia ^b   Magoni, Mauro ^c   Sacchi, Lucia ^d   Quaglini, Silvana ^d   Lanzola, Giordano ^d   Micieli, Giuseppe ^a   Adobbati, Laura ^e   Silani, Vincenzo ^e   Agostoni, Elio ^f   Scaccabarozzi, Chiara ^f   Arnaboldi, Marco ^g   Vidale, Simone ^g   Baietti, Gianstefano ^h   Bettoni, Luigi ^h   Balducci, Ubaldo ⁱ   Chia, Francesco ⁱ   Baron, Pierluigi ^j   Bresolin, Nereo ^j   Bassi, Pietro ^k   Bazzi, Paola ^l   Crespi, Vittorio ^l   Beretta, Simone ^m   Ferrarese, Carlo ^m   Bet, Luciano ⁿ   Meola, Giovanni ⁿ   Bezzi, Giacomo ^o   Boncoraglio, Giorgio ^p   Parati, Eugenio ^p   Bono, Giorgio ^q   Delodovici, Maria Luisa ^q   Bordo, Bianca ^l   Colombo, Antonio ^l   Borutti, Giuseppina ^r   Piccolo, Giovanni ^r   Brusaferri, Fabio ^s   Prelle, Alessandro ^s   Calloni, Maria Vittoria ^b   Camerlingo, Massimo ^t   Censori, Bruno ^u   Cerini, Carlo ^v   Turla, Marinella ^v   Checcarelli, Nicoletta ^w   Guidotti, Mario ^w   Comi, Giancarlo ^x   Sessa, Maria ^x   Costa, Angelo ^c   Donati, Edoardo ^y   Ferrante, Claudio ^z   Frediani, Fabio ^aa   Lattuada, Patrizia ^aa   Poloni, Emanuele ^aa   Gambaro, Paola ^ab   Mariani, Claudio ^ab   Gomitoni, Antonella ^ac   Grampa, Giampiero ^ac   Lanza, Ezio ^ad   Magnoni, Andrea ^ae   Marcheselli, Simona ^af   Marsile, Claudia ^ag   Molini, Graziella ^ag   Sasanelli, Francesco ^ag   Martignoni, Alessandra ^ah   Mattioli, Marco ^ai   Neromante, Irene ^aj   Porazzi, Daniele ^aj   Poloni, Marco ^ak   Previdi, Paolo ^al   Silvestrelli, Giorgio ^al   Riva, Maurizio ^am   Zilioli, Angelo ^am   Romorini, Alessandro ^an   Santilli, Ignazio ^ao   Tadeo, Carlo Sebastiano ^ap   Zaccone, Maria Teresa ^aq   Zarcone, Davide ^ar   more..

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b Legnano Hospital   (Italy)

^c SPEDALI CIVILI   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^f A MANZONI HOSPITAL   (Italy)

^g SANT ANNA HOSPITAL   (Italy)

^h Cremona Hospital   (Italy)

ⁱ Chiari Hospital   (Italy)

^j FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^k S Giuseppe Hospital   (Italy)

^l DESIO HOSPITAL   (Italy)

^m Department of Pediatrics   (Italy)

ⁿ IRCCS POLICLINICO SAN DONATO   (Italy)

^o Sondrio Hospital   (Italy)

^p DEPARTMENT OF NEUROSURGERY   (Italy)

^q Macchi Hospital   (Italy)

^r Voghera Hospital   (Italy)

^s Crema Hospital   (Italy)

^t 'San Marco' Policlinico   (Italy)

^u 'Riuniti' di Bergamo Hospital   (Italy)

^v Esine Hospital   (Italy)

^w VALDUCE HOSPITAL   (Italy)

^x SAN RAFFAELE HOSPITAL   (Italy)

^y 'Poliambulanza' Hospital   (Italy)

^z Clinical Pathology Service   (Italy)

^aa SAN CARLO BORROMEO HOSPITAL   (Italy)

^ab UNIVERSITY OF MILAN   (Italy)

^ac Saronno Hospital   (Italy)

^ad TREVIGLIO HOSPITAL   (Italy)

^ae Palliative Care Unit   (Italy)

^af HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^ag Vizzolo Predabissi Hospital   (Italy)

^ah 'San Matteo' Policlinico IRCCS   (Italy)

^ai Garbagnate Hospital   (Italy)

^aj BUSTO ARSIZIO HOSPITAL   (Italy)

^ak 'Riuniti' Hospital   (Italy)

^al Mantova Hospital   (Italy)

^am Lodi Hospital   (Italy)

^an Magenta Hospital   (Italy)

^ao OSPEDALE NIGUARDA CA GRANDA   (Italy)

^ap 'Citt' Studi' Clinical Institute   (Italy)

^aq Clinical Institute 'Beato Matteo'   (Italy)

^ar Gallarate Hospital   (Italy)

more..

Author keywords

Adherence; Classification tree; Ischemic stroke; Performance predictors; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; DISABILITY; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRESCRIPTION; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; TREATMENT CONTRAINDICATION;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITALY; MALE; REGISTRIES; RISK FACTORS; STROKE;

EID: 84898936156     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-53     Document Type: Article

References (62)

1. Calabrò P, Yeh ET. The pleiotropic effects of statins. Curr Opin Cardiol 2005, 20(6):541-6. 10.1097/01.hco.0000181482.99067.bf, 16234628.
2. Stead LG, Vaidyanathan L, Kumar G, Bellolio MF, Brown RD, Suravaram S, Enduri S, Gilmore RM, Decker WW. Statins in ischemic stroke: just low-density lipoprotein lowering or more?. J Stroke Cerebrovasc 2009, 18(2):124-127.
3. Prinz V, Endres M. Statins and stroke: prevention and beyond. Curr Opin Neurol 2011, 24(1):75-80. 10.1097/WCO.0b013e3283424c53, 21150596.
4. Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 2007, 13(3):208-13. 10.1177/1073858406297121, 17519364.
5. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355(6):549-59. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.
6. Vergouwen MDI, De Haan RJ, Vermeulen M, Roos YB. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008, 39(2):497-502. 10.1161/STROKEAHA.107.488791, 18174491.
7. Sacco S, Toni D, Bignamini AA, Zaninelli A, Gensini GF, Carolei A, the SIRIO Study Group Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol 2011, 26(3):133-9. 3814556, 22152434, the SIRIO Study Group.
8. Flint AC, Kamel H, Navi BB, Rao VA, Faigeles BS, Conell C, Klingman JG, Sidney S, Hills NK, Sorel M, Cullen SP, Johnston SC. Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke 2012, 43(1):147-54. 10.1161/STROKEAHA.111.627729, 22020026.
9. Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, Rost NS. Statin treatment and functional outcome after ischemic stroke case-control and meta-analysis. Stroke 2011, 42(5):1314-9. 10.1161/STROKEAHA.110.605923, 3093764, 21415396.
10. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, MacLeod MJ, Sillesen H, Zweifler R, Michael K, Welch A. Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial. Stroke 2009, 40(11):3526-31. 10.1161/STROKEAHA.109.557330, 19745172.
11. Milionis HJ, Giannopoulos S, Kosmidou M, Panoulas V, Manios E, Kyritsis AP, Elisaf MS, Vemmos K. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival. Neurology 2009, 72(21):1816-22. 10.1212/WNL.0b013e3181a711cb, 19470963.
12. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta analysis of statins for stroke prevention. Lancet Neurol 2009, 8(5):453-63. 10.1016/S1474-4422(09)70058-4, 19375663.
13. O'Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121 000 patients. Am J Med 2008, 121(1):24-33. 10.1016/j.amjmed.2007.06.033, 18187070.
14. SPREAD (Stroke Prevention and Educational Awareness Diffusion) Guidelines. Via Alberto Falck, 15, 20099 Sesto San Giovanni - Milano: Pierrel Research Italy SpA, 7, Version of 14th March 2012. http://www.siapav.it/pdf/SPREAD%202012.pdf.
15. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch Y, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D, on behalf of the American Heart Association Stroke Council AHA/ASA Guideline - Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011, 42(1):227-76. 10.1161/STR.0b013e3181f7d043, 20966421, on behalf of the American Heart Association Stroke Council.
16. European Stroke Organisation (ESO) Executive Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25(5):457-507. European Stroke Organisation (ESO) Executive Committee.
17. Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2013, [Epub ahead of print].
18. Keaney JF, Curfman GD, Jarcho JA. A pragmatic view of the new cholesterol treatment guidelines. N Engl J Med 2014, 370(3):275-8. 10.1056/NEJMms1314569, 24283199.
19. Castilla-Guerra L, Espino-Montoro A, Fernández-Moreno MC, López-Chozas JM, Jimernez MD. Statins and stroke. Current clinical practice. Stroke 2006, 37(5):1153.
20. Ovbiagele B, Saver JL, Bang H, Chambless LE, Nassief A, Minuk J, Toole JF, Crouse JR. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology 2006, 66(8):1164-70. 10.1212/01.wnl.0000208403.18885.0e, 16636231.
21. Ovbiagele B, Schwamm LH, Smith EE, Hernandez AF, Olson DWM, Pan W, Fonarow GC, Saver JL. Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. Stroke 2010, 41(7):1508-13. 10.1161/STROKEAHA.109.573618, 20508182.
22. Asberg S, Henriksson KM, Farahmand B, Asplund K, Norrving B, Appelros P, Stegmayr B, Asberg KH, Terént A. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish stroke register. Stroke 2010, 41(7):1338-42. 10.1161/STROKEAHA.110.580209, 20522818.
23. Mullard AJ, Reeves MJ, Jacobs BS, Kothari RU, Birbeck GL, Maddox K, Stoeckle-Roberts S, Wehner S, Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry. Stroke 2006, 37(1):44-9. 10.1161/01.STR.0000195127.12990.43, 16339479, Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators.
24. Micieli G, Cavallini A, Quaglini S, Fontana G, Duè M. The Lombardia Stroke Unit Registry: 1-year experience of a web-based hospital stroke registry. Neurol Sci 2010, 31(5):555-64. 10.1007/s10072-010-0249-x, 20339888.
25. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicentre clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24(1):35-41. 10.1161/01.STR.24.1.35, 7678184.
26. Venables WN, Ripley BD. Modern applied statistics with S 2002, Fourth Edition: Springer.
27. Demsar J, Zupan B. Orange: from experimental machine learning to interactive data mining. White Paper (http://www.ailab.si/orange) 2004, Faculty of Computer and Information Science, University of Ljubljana.
28. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction 2009, Springer, Second.
29. Li X, Gao Y, Li J, Feng F, Liu JM, Zhang HB, Zhang D, Hundei WH, Chen F, Chen YP, Chen ZM, Landray M, Armitage J, Jiang LX, Li LM, HPS2-THRIVE China group Underuse of statins in patients with atherosclerotic ischemic stroke in China. Chin Med J (Engl) 2012, 125(10):1703-7. HPS2-THRIVE China group.
30. Garjon FJ, Azparren A, Vergara I, Azaola B, Loayssa JR. Adoption of new drugs by physicians: a survival analysis. BMC Health Serv Res 2012, 12:56. 10.1186/1472-6963-12-56, 3353238, 22401169.
31. Chauhan D, Mason A. Factors affecting the uptake of new medicines in secondary care - a literature review. J Clin Pharm Ther 2008, 33(4):339-48. 10.1111/j.1365-2710.2008.00925.x, 18613851.
32. Ohlsson H, Merlo J. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type? - A multilevel logistic regression analysis in South Sweden. Pharmacoepidemiol Drug Saf 2009, 18(8):682-90. 10.1002/pds.1767, 19437457.
33. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D, European BIOMED Study of Stroke Care Group Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003, 34(5):1114-9. 10.1161/01.STR.0000068410.07397.D7, 12690218, European BIOMED Study of Stroke Care Group.
34. Hjalmarsson C, Bokemark L, Manhem K, Mehlig K, Andersson B. The effect of statins on acute and long-term outcome after ischemic stroke in the elderly. Am J Geriatr Pharmacother 2012, 10(5):313-22. 10.1016/j.amjopharm.2012.09.001, 23063287.
35. Mauskop A, Borden WB. Predictors of statin adherence. Curr Cardiol Rep 2011, 13(6):553-8. 10.1007/s11886-011-0221-2, 21947789.
36. Lummis HL, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol 2008, 8:25. 10.1186/1471-2377-8-25, 2474854, 18616796.
37. Savarese G, Gotto AM, Paolillo S, D'Amore C, Losco T, Musella F, Scala O, Marciano C, Ruggiero D, Marsico F, De Luca G, Trimarco B, Perrone-Filardi P. Benefits of statins in elderly subjects without established cardiovascular disease. a meta-analysis. J Am Coll Cardiol 2013, 14. [E-pub ahead of print].
38. Nì Chròinìn D, Nì Chròinìn C, Callaly EL, Hannon N, Kelly L, Marnane M, Merwick A, Shhehan O, Hirgan G, Duggan J, Kyne L, Dolan E, Moore A, Williams D, Kelly PJ. Suboptimal lipid management in ischaemic stroke and TIA patients - The North Dublin population stroke study. Cerebrovasc Dis 2013, 35(Suppl 3).
39. Kablau M, Kreisel SH, Sauer T, Binder J, Szabo K, Hennerici MG, Kern R. Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis 2011, 32(4):334-41. 10.1159/000331702, 21921596.
40. Goldstein LB, Amarenco P, Szarek M, Callahan A, Hennerici M, Sillesen H, Zivin JA, Welch KM, SPARCL Investigators Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008, 70(24 Pt 2):2364-70. SPARCL Investigators.
41. LaRosa JC, Pedersen TR, Somaratne R, Wasserman SM. Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events. Am J Cardiol 2013, 111(8):1221-9. 10.1016/j.amjcard.2012.12.052, 23375731.
42. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J. Better outcome after stroke with higher serum cholesterol levels. Neurology 2000, 54(10):1944-9. 10.1212/WNL.54.10.1944, 10822434.
43. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Eng J Med 1989, 320(14):904-10.
44. Suzuki K, Izumi M, Sakamoto T, Hayashi M. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis 2011, 31(1):100-6. 10.1159/000321506, 21079399.
45. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J, Messig M, Welch KM, Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008, 39(12):3297-302. 10.1161/STROKEAHA.108.516450, 18845807, Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators.
46. Day JS, Policeni BA, Smoker WR, Dobre MC, Zhang Y, Leira EC, Davis PH, Chen S, Olalde H, Adams HP. Previous statin use is not associated with an increased prevalence or degree of gradient-echo lesions in patients with acute ischemic stroke or transient ischemic attack. Stroke 2011, 42(2):354-8. 10.1161/STROKEAHA.110.594101, 21164134.
47. Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke 2012, 43(10):2677-81. 10.1161/STROKEAHA.112.657486, 22829545.
48. Furie K. High-dose statins should only be used in atherosclerotic strokes. Stroke 2012, 43(7):1994-5. 10.1161/STROKEAHA.111.633339, 22581818.
49. Àlvarez-Sabìn J, Huertas R, Quintana M, Delgado P, Ribo M, Molina CA, Montaner J. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator. Stroke 2007, 38(3):1076-8. 10.1161/01.STR.0000258075.58283.8f, 17272777.
50. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, Luijckx GJ, De Keyser J. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischemic stroke. J Neurol 2008, 255(6):875-80. 10.1007/s00415-008-0797-7, 18338194.
51. Meier N, Nedeltchev K, Brekenfeld C, Galimanis A, Fischer U, Findling O, Remonda L, Schroth G, Mattle HP, Arnold M. Prior statin use, intracranial hemorrhage and outcome after intra-arterial thrombolysis for acute ischemic stroke. Stroke 2009, 40(5):1729-37. 10.1161/STROKEAHA.108.532473, 19265056.
52. Engelter ST, Soinne L, Ringleb P, Sarikaya H, Bordet R, Berrouschot J, Odier C, Arnold M, Ford GA, Pezzini A, Zini A, Rantanen K, Rocco A, Bonati LH, Kellert L, Strbian D, Stoll A, Meier N, Michel P, Baumgartner RW, Leys D, Tatlisumak T, Lyrer PA. IV thrombolysis and statins. Neurology 2011, 77(9):888-95. 10.1212/WNL.0b013e31822c9135, 21849650.
53. Cappellari M, Deluca C, Tinazzi M, Tomerelli G, Carletti M, Fiaschi A, Bovi P, Moretto G. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study. J Neurol Sci 2011, 308(1-2):128-34.
54. Cappellari M, Bovi P, Moretto G, Zini A, Nencini P, Sessa M, Furlan M, Pezzini A, Orlandi G, Paciaroni M, Tassinari T, Procaccianti G, Di Lazzaro V, Bettoni L, Gandolfo C, Silvestrelli G, Rasura M, Martini G, Melis M, Calloni MV, Chiodo-Grandi F, Beretta S, Guarino M, Altavista MC, Marcheselli S, Galletti G, Adobbati L, Del Sette M, Mancini A, Orrico D, et al. The THRombolysis and STatins (THRaST) study. Neurology 2013, 80(7):655-61. 10.1212/WNL.0b013e318281cc83, 3590058, 23345634.
55. Ní Chròinín D, Callaly E, Duggan J, Merwick A, Hannon N, MB, Sheehan O, Marnane M, Horgan G, Williams EB, Harris D, Kyne L, McCormack PM, Moroney J, Grant T, Williams D, Daly L, Kelly PJ. Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke The North Dublin Population Stroke Study. Stroke 2011, 42(4):1021-9. 10.1161/STROKEAHA.110.596734, 21372311.
56. Lakhan SE, Bagchi S, Hofer M. Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med 2010, 3:22. 10.1186/1755-7682-3-22, 2954982, 20920225.
57. Hackam D, Woodward M, Newby K, Bhatt D, Shao M, Smith EE, Donner A, Mamdani M, Douketis JD, Arima H, Chalmers J, MacMahon S, Tirschwell DL, Psaty BM, Bushnell CD, Aguilar MI, Capampangan DJ, Werring DJ, De Rango P, Viswanathan A, Danchin N, Cheng CL, Yang YH, Verdel BM, Lai MS, Kennedy J, Uchiyama S, Yamaguchi T, Ikeda Y, Mrkobrada M. Statins and Intracerebral Hemorrhage Collaborative Systematic Review and Meta-Analysis. Circulation 2011, 124(20):2233-42. 10.1161/CIRCULATIONAHA.111.055269, 22007076.
58. Montaner J, Chacòn, Krupinski J, Rubio F, Millàn M, Molina CA, Hereu P, Quintana M, Alvarez-Sabín J. Simvastatin in acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008, 15(1):82-90.
59. D'Amelio M, Terruso V, Famoso G, Ragonese P, Aridon P, Savettieri G. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis 2011, 32(3):234-8. 10.1159/000329315, 21860236.
60. Selim MH, Molina CA. High-dose statin for every stroke. The good, the bad, and the unknown. Stroke 2012 Jul, 43(7):1996-7.
61. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Sacco RL, Schwamm LH, American Heart Association Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008, 39(5):1647-52. 10.1161/STROKEAHA.107.189063, 18322260, American Heart Association.
62. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association/American Stroke Association Stroke Council Guidelines for the early management of adults with ischemic stroke. Circulation 2007, 115(20):e478-534. 10.1161/CIRCULATIONAHA.107.181486, 17515473, American Heart Association/American Stroke Association Stroke Council.